Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reports that patients with alopecia areata in the US incur significantly higher healthcare utilization and expenses, primarily driven by ambulatory and pharmacy costs, compared to matched controls.

This study found that racial minorities face higher costs for unplanned hospital visits after surgery despite controlling for insurance, highlighting health care disparities and suggesting revised payment models as a potential mitigation strategy.

This study suggests that while adding baricitinib to formularies may increase costs for government hospitals, it could expand treatment options and potentially improve outcomes for patients with AA. Further analyses are recommended to assess its cost-effectiveness in terms of outcomes improvement.

Double trichophytic closure effectively treats thin scalp scars and reduces patient costs.

Targeted testing for telogen effluvium patients can save healthcare costs.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

This study observed that using DNA nanostructures to deliver chemotherapy drugs could potentially reduce costs compared to traditional methods, with financial barriers being less significant than technical, regulatory, and ethical challenges.

This study observed that patients with alopecia areata often have comorbidities and experience significant healthcare costs, with treatments like systemic therapies being infrequently used.

In this study, finasteride was found to reduce costs associated with benign prostatic hyperplasia compared to watchful waiting and terazosin, especially in men with higher prostate-specific antigen levels.

This study reported that women with alopecia often face high out-of-pocket costs for over-the-counter treatments and camouflaging agents due to insufficient insurance coverage, which can significantly impact their financial well-being and ability to afford basic necessities.

This study found that patients on dutasteride had $20.50 lower monthly medical costs compared to those on finasteride.

This article describes a new T-Fast multi-implanter that potentially reduces operating costs and surgical time by implanting two follicular unit excision grafts simultaneously, which may encourage clinics to adopt this technique.

The letters discussed medical tools, costs, treatment efficacy, and patient care complexities.

This study concluded that combining vertical and transverse sections of scalp biopsy specimens improves diagnostic yield for certain hair disorders without increasing costs.

This study concluded that visits to emergency and urgent care centers for severe sunburn treatment are largely avoidable and contribute to significant healthcare costs.

PCOS leads to various immediate and long-term health problems, affecting quality of life and increasing costs.

This article narrates a case where a patient with androgenetic alopecia faced high out-of-pocket costs for finasteride 1 mg and sought to reduce expenses by requesting a prescription for 5 mg tablets typically used for BPH, which are covered by insurance.

This study reviews the transformative role of artificial intelligence in biomaterial design, highlighting its ability to reduce costs through virtual screening, enhance material performance, and predict biological interactions to advance personalized and precision medicine.

In this study, individuals with alopecia areata in the UK incurred significant costs for managing their condition, with those experiencing more severe symptoms and lower disposable income facing higher financial burdens.

This study analyzed the economic burden of alopecia areata in Saudi Arabia, finding significant costs driven by productivity loss and drug expenses, with severe cases incurring higher expenses, emphasizing the need for better treatment protocols and access to therapies.

This article discusses female hair transplant procedures in Pakistan, highlighting their growing popularity despite high costs and limited clinic availability, but reports no new clinical results.

This study found that the prevalence of statin users in South Korea increased annually by 12%, with those having comorbidities like coronary disease and diabetes incurring higher medical costs.

This study found that surgical deactivation of migraine trigger sites significantly reduced or eliminated migraine symptoms in most treated patients, compared to controls, and also decreased migraine-associated costs and workdays lost.

This review suggests that omitting the proteolysis step and including tissue pieces in mesenchymal stem cell isolation may improve cell quality, reduce contamination risk, and lower costs and processing time in clinical applications.

This study reported that palliative chemotherapy prolonged overall and quality-adjusted survival in patients with advanced gastric cancer, with improved quality of life compared to best supportive care, but increased costs.

This paper reviews AI integration in robotic surgical systems, highlighting enhanced precision and reduced fatigue but noting challenges like high costs and ethical concerns, suggesting responsible adoption to realize potential benefits for surgical care.

This article discusses drug repurposing as a strategy to find new uses for existing medications, highlighting its potential benefits like faster development and lower costs, while also addressing challenges such as drug specificity, ethical concerns, and regulatory issues.

This study found that patients, oncologists, and payers prioritize a significant improvement in efficacy to justify the added risks and costs when considering CDK4/6 inhibitors combined with endocrine therapy for early-stage breast cancer.

This article compares modern hair restoration techniques for androgenic alopecia, focusing on procedure times, labor, and costs, but it does not provide new clinical findings.

This study highlights the potential benefits and current limitations of robotic systems in nipple-sparing mastectomies, noting their promise in reducing surgeon fatigue but pointing out challenges such as longer operating times, high costs, and limited haptic feedback.